CSI Market
Sign In | Register

Gsk Plc (GSK) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access GSK Annual Income Statement →
This income statement overview for Gsk Plc spans from Dec 31 2024 to Dec 31 2025, showing how the company's revenues, expenses, and earnings have changed across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
Q4 2025 		0 0 0 (Dec 31 2024)
Revenues
Total Revenue43,093.89
Costs & Expenses
Cost of Goods and Services Sold11,895.11
Gross Profit31,198.78
Selling, Administration, Marketing11,988.77
Depreciation & Amortization3,052.60
Research and Development Expense9,926.88
OtherOperating Income Expense21.11
Total operating costs including COS32,630.10
Operating income / -loss10,463.79
Net Interest (-)Expense / Income0.00
Other loss / -income-1.32
Total costs & expenses33,330.58
Income & Taxes
Income / -loss before income taxes9,763.30
Income taxes expenses / -benefit1,466.94
Income after income taxes8,296.37
Net income / -loss of other equity0.00
Income / -loss from continuing operations8,296.37
Non-controlling interests1,488.04
Net income / -loss8,296.37
Income / -loss to shareholder7,540.47
EBIT9,763.30
EBITD9,763.30
EBITDA9,763.30
Earnings Per Share
Basic EPS (excl. extra items)0.00
Basic Net EPS0.00
Diluted Net EPS0.00
4 historic quarters locked

Sign in to unlock the full Gsk Plc income statement history.

Sign In Create Free Account

About GSK Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.